Embody vs MangoRx: Which GLP-1 Provider Is Better?
By Iacob Pastina, Independent Researcher
MangoRx beats Embody overall, scoring 7.5/10 vs 7.3/10. Choose Embody for users looking for the lowest entry price with round-the-cloc. Choose MangoRx for users who want a multi-service telehealth platform covering .
A side-by-side comparison of Embody and MangoRx covering pricing, scores, medication types, insurance, and more to help you decide.
Embody
#31 of 40Compounded GLP-1 provider with 24/7 specialist support and competitive pricing for budget-conscious users.
Visit EmbodyMangoRx
#23 of 40Multi-service telehealth platform offering compounded GLP-1 alongside other health services.
Visit MangoRx| Feature | Embody | MangoRx |
|---|---|---|
| Our Score | 7.3/10 | 7.5/10 |
| Starting Price | $299/mo | $299/mo |
| Medication Type | Compounded | Compounded |
| Insurance Accepted | No | No |
| Best For | Users looking for the lowest entry price with round-the-clock specialist support | Users who want a multi-service telehealth platform covering weight loss and men's health |
| Ranking | #31 | #23 |
Pros & Cons Compared
Embody
Pros
- +$149 first month is one of the lowest entry prices in the GLP-1 market — includes medication, metabolic report, and 1:1 guidance
- +Oral tirzepatide gum format available — one of the few platforms offering a non-injectable tirzepatide option for needle-phobic patients
- +24/7 specialist support included at no extra cost for questions about dosing, side effects, and progress
- +Personalized metabolic report helps you understand your body's baseline before starting treatment
Cons
- −Monthly refill price jumps to $299/mo after the first month — nearly double what competitors like Mochi ($99/mo + membership) or TrimRx ($179/mo) charge
- −Compounded medications only — no brand-name Wegovy or Zepbound available through the platform
- −Limited company transparency — founding date, headquarters, and pharmacy partners are not publicly disclosed
MangoRx
Pros
- +Oral dissolving tablets exclusively — zero injections for any GLP-1 option
- +Publicly traded on NASDAQ (MGRX) — SEC-required financial transparency that private competitors can't match
- +Semaglutide tablet includes Vitamin B6 to help reduce nausea during treatment
- +Free 100% online consultation with no video call required
Cons
- −$299/mo for oral semaglutide is 2-3x the cost of injectable alternatives at $99-149/mo
- −Early-stage public company with limited revenue — stock performance reflects financial uncertainty
- −Only oral tablet format available — no injectable options if you want higher bioavailability
Our Verdict
MangoRx edges out Embody with a score of 7.5/10 vs 7.3/10. Choose Embody if you want: users looking for the lowest entry price with round-the-clock specialist support. Choose MangoRx if you want: users who want a multi-service telehealth platform covering weight loss and men's health.